Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: A review

Drug and Alcohol Review

Volumn 28, Issue 6, 2009, Pages 669-675

  Topp, Libby ^a   Day, Carolyn ^b   Dore, Gregory J ^c   Maher, Lisa ^c  

^a JUSTICE HEALTH AND FORENSIC MENTAL HEALTH NETWORK   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Criterion validity; Hepatitis B; Intravenous; Self report; Serological test; Substance abuse

Indexed keywords

HEPATITIS B VACCINE;

BLOOD; HEPATITIS B; HUMAN; PATIENT SELECTION; REVIEW; SUBSTANCE ABUSE; VALIDATION STUDY;

HEPATITIS B; HEPATITIS B VACCINES; HUMANS; PATIENT SELECTION; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 76949102648     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2009.00060.x     Document Type: Review

References (57)

1. World Health Organization. Hepatitis B vaccines: WHO position paper. Wkly Epidemiol Rec 2004;79:255-63.
2. François G, Hallauer J, van Damme P. Hepatitis B vaccination: how to reach risk groups. Vaccine 2002;21:1-4.
3. Tawk HM, Vickery K, Bisset L, et al. The current pattern of hepatitis B infection in Australia. J Viral Hepat 2006;13: 206-15.
4. Hoofnagle JH. Type B hepatitis: virology, serology and clinical course. Semin Liver Dis 1981;1:7-14.
5. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998;51:253-63.
6. Kalichman SC, Rompa D, Cage M. Reliability and validity of self-reported CD4 lymphocyte count and viral load test results in people living with HIV/AIDS. Int J STD AIDS 2000;11:579-85.
7. Fisher DG, Reynolds GL, Jaffe A, Johnson ME. Reliability, sensitivity and specificity of self-report of HIV test results. AIDS Care 2007;19:692-6.
8. Last JM. A dictionary of epidemiology, 4th edn. Oxford: Oxford University Press, 2001.
9. Kleyn J, Schwebke J, Holmes KK. The validity of injecting drug users' self-reports about sexually transmitted diseases: a comparison of survey and serological data. Addict 1993; 88:673-80.
10. Fisher DG, Kuhrt-Hunstiger T, Orr SM, Davis DC. Hepatitis B validity of drug users' self-report. Psychol Addict Behav 1999;13:33-8.
11. Rhodes T, Hunter GM, Stimson GV, et al. Prevalence of markets for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviours. Addict 1996;91:1457-67.
12. Lamagni TL, Davison KL, Hope VD, et al. Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996. Commun Dis Public Health 1999;2:174-7.
13. Best D, Noble A, Finch E, Gossop M, Sidwell C, Strang J. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. BMJ 1999;319:290-1.
14. Butler T, Spencer J, Cui J, Vickery K, Zou J, Kaldor J. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners-NSW, 1996. Aust N Z J Public Health 1999;23:377-84.
15. Schlicting EG, Johnson ME, Brems C, Fisher DG, Reynolds G. Validity of injecting drug users' self report of hepatitis A, B, and C. Clin Lab Sci 2003;16:99-106.
16. Kuo I, Mudrick DW, Strathdee SA, Thomas DL, Sherman SG. Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users. Clin Infect Dis 2004;38:587-90.
17. Lo Re V, Frank I, Gross R, et al. Self-reported hepatitis B and C virus infection had low sensitivity among HIVinfected patients. J Clin Epidemiol 2007;60:294-9.
18. Mahoney FJ. Update on diagnosis, management and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999;12:351-66.
19. Karpati A, Galea S, Awerbuch T, Levins R. Variability and vulnerability at the ecological level: implications for understanding the social determinants of health. Am J Public Health 2002;92:1768-72.
20. Alberti A, Clumeck N, Collins S, et al. Short statement of the First European Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2005;42:615-24.
21. Rousseau MC, Moreau J, Delmout J. Vaccination and HIV: a review of the literature. Vaccine 2000;18:825-31.
22. Greer S, Alexander GJM. Viral serology and detection. Baillière's Clin Gastroenterol 1995;9:689-721.
23. Parry JV, Perry KR, Mortimer PP. Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 1987;2:72-5.
24. Comfort MB, Wu PC. The reliability of personal and family medical histories in the identification of hepatitis B carriers. Oral Surg Oral Med Oral Pathol 1989;67:531-4.
25. Hart GJ, Dawson J, Fitzpatrick RM. Risk behavior, anti-HIV and anti-hepatitis B core prevalence in clinic and nonclinic samples of gay men in England. AIDS 1993;7:863-9.
26. Hagan H, Campbell J, Thiede H, et al. Self-reported hepatitis C virus antibody status and risk behaviour in young injectors. Public Health Rep 2006;121:710-19.
27. Stein MD, Maksad J, Clarke J. Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug Alcohol Depend 2007;61: 211-15.
28. Butler T, Boonwaat L, Hailstone S. National Prisons Entrants' Bloodborne Virus Survey Report, 2004. Sydney: Centre for Health Research in Criminal Justice and National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 2005.
29. Butler T, Papanastasiou C. National Prison Entrants' Bloodborne Virus and Risk Behaviour Survey Report 2004 & 2007. Perth: National Drug Research Institute (Curtin University) and National Centre in HIV Epidemiology and Clinical Research, University of New SouthWales, 2008.
30. de la Fuente L, Toro C, Brugal MT, et al. Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy 'don't ask, draw a blood sample, vaccinate and try to schedule another visit'. J Clin Virol 2007;38:87-90.
31. Polizzotto MN, Whelan G. Hepatitis B immunity in a population of drug and alcohol users. Drug Alcohol Rev 2007;26:417-19.
32. Tawk HM, Vickery K, Bisset L, Selby W, Cossart YE. The impact of hepatitis B vaccination in a Western country: recall of vaccination and serological status in Australian adults. Vaccine 2006;24:1095-106.
33. Wong VK, Woodruff C, Shapiro R. Compliance of hepatitis B vaccination in patients presenting to a teenage clinic. Pediatr Infect Dis J 1994;13:936.
34. Thompson S, Ogilvie E, Veit F, Crofts N. Serostatus for vaccine-preventable diseases in residents at Melbourne Juvenile Justice Center. Aust N Z J Public Health 1998; 22:573-8.
35. Pallecaros A, Robinson A. Hepatitis B vaccination. BMJ 1996;312:777.
36. Heimer R, Clair S, Grau LE, Bluthenthal RN, Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addict 2002;97:1277-87.
37. Levine O, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users. Am J Epidemiol 1995; 142:331-41.
38. Seal KH, Kral AH, Lorvick J, McNees A, Gee L, Edlin BR. Randomized controlled trial of monetary incentives versus outreach to enhance adherence to HBV vaccine series among IDU. Drug Alcohol Depend 2003;71:127-31.
39. Baral S, Sherman SG, Millson P, Beyrer C. Vaccine immunogenicity in injecting drug users: a systematic review. Lancet Infect Dis 2007;7:667-74.
40. Lum PJ, Ochoa KC, Hahn JA, Page-Shafer K, Evans JL, Moss AR. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. Am J Public Health 2003;93:919-23.
41. Quaglio G, Talamini G, Lugoboni F, et al. Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine response. Addict 2002;97: 985-92.
42. Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999;149:203-13.
43. Hahn JA, Page-Schafer K, Lum PJ, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002;186:1558-64.
44. Judd A, Hickman M, Jones S, et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ 2005;330:24-5.
45. Maher L, Jalaludin B, Chant KG, et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addict 2006;101:1499-508.
46. Amin J, Law M, Bartlett M, Kaldor J, Dore G. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006;368: 938-45.
47. Jilg W, Schmidt M, Deinhardt F. Vaccination against hepatitis B: comparison of three different vaccination schedules. J Infect Dis 1989;160:766-9.
48. Lugoboni F, Migliozzi S, Schiesari F, et al. Immunoresponse to hepatitis B vaccination and adherence campaign among injecting drug users. Vaccine 1997;15:1014-16.
49. Rodrigo JM, Serra MA, Aparisi L, et al. Immune response to hepatitis B vaccine in parenteral drug abusers. Vaccine 1992;10:798-801.
50. Wright NMJ, Campbell TL, Tompkins CNE. Comparison of conventional and accelerated hepatitis B immunization schedules for homeless drug users. Commun Dis Public Health 2002;5:324-6.
51. Des Jarlais D, Fisher D, Newman J, et al. Providing hepatitis B vaccination to injection drug users: referral to health clinics versus on-site vaccination at a syringe exchange program. Am J Epidemiol 2001;91:1791-2.
52. Mezzelani P, Venturini L, Turrina G, Lugoboni F, Des Jarlais D. High compliance with a hepatitis B virus vaccination program among intravenous drug users. J Infect Dis 1991;163:923-4.
53. Hope VD, Ncube F, Hickman M, Judd A, Parry JV. Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements? J Viral Hep 2007;14:653-60.
54. Lum PJ, Hahn JA, Page-Shafer K, et al. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco. J Viral Hepat 2008; 15:229-36.
55. Rich JD, Ching CG, Lally MA, et al. A review of the case for hepatitis B vaccination of high-risk adults. Am J Med 2003; 114:316-18.
56. Kuo I, Sherman S, Thomas D, Strathdee S. Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection. Drug Alcohol Depend 2004;73:69-78.
57. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997;33:196-204.